UCSF

ZINC08214590

Substance Information

In ZINC since Heavy atoms Benign functionality
July 4th, 2006 33 No

Other Names:

mycin

25389-94-0; C08046; Kanamycin monosulfate; Kanamycin sulfate

25389-94-0; D00866; Kanamycin monosulfate (JP16); Kanamycin sulfate (USP); Kantrex (TN)

4,6-diamino-2-hydroxy-1,3-cyclohexane 3,6'diamino-3,6'-dideoxydi-alpha-D-glucoside; 4,6-diamino-2-hydroxy-1,3-cyclohexylene 3,6'-diamino-3,6'-dideoxydi-D-glucopyranoside; KANAMYCIN A; O-3-amino-3-deoxy-alpha-D-glucopyranosyl-(1->6)-O-(6-amino-6-deoxy-alph

4,6-Diamino-2-hydroxy-1,3-cyclohexane 3,6'diamino-3,6'-dideoxydi-alpha-D-glucoside; BRN 0061647; C18H36N4O11; D-Streptamine, O-3-amino-3-deoxy-alpha-D-glucopyranosyl-(1-6)-O-(6-amino-6-deoxy-alpha-D-glucopyranosyl-(1,4))-2-deoxy-; D-Streptamine, O-3-amino

59-01-8; C01822; Kanamycin A

Aminodeoxykanamycin

Aminodeoxykanamycin;KAN;Kanamycin Base;Kanamycin Sulfate;Nebramycin Factor 5

Bekanamycin

CHEBI:43482; CHEBI:14487; CHEBI:24945; CHEBI:24947; CHEBI:28008; CHEBI:6106

CPD-4821; kanamycin A

D03262; KM; Kanamycin sulfate (JP16); Kanamycin sulfate (TN)

INN); Kanamycin Monosulfate (JAN); Kanamycin Sulfate (FDA

JAN

KAN

KAN;Aminodeoxykanamycin;Kanamycin Base;Kanamycin Sulfate;Nebramycin Factor 5

Kanamycin

Kanamycin (BAN

Kanamycin A

Kanamycin A sulfate; Kanamycin acid sulfate; Kanamycin monosulfate; Kanamycin sulfate; Kantrex

kanamycin A(4+)

kanamycin A; kanamycin A tetracation

Kanamycin acid sulphate

Kanamycin acid sulphate, Antibiotic for Culture Media Use Only

Kanamycin B

Kanamycin Base

Kanamycin dipantothenate; Kanamycin, di-D-pantothenate (salt); Kanamycin, pantothenate (1:2); LS-16062; beta-Alanine, N-(2,4-dihydroxy-3,3-dimethyl-1-oxobutyl)-, (R)-, compd. with O-3-amino-3-deoxy-alpha-D-glucopyranosyl-(1-6)-O-(6-amino-6-deoxy-alpha-D-g

Kanamycin Sulfate

Kanamycin sulfate, Antibiotic for Culture Media Use Only

Kenamycin A

Klebcil

Nebramycin Factor 5

USP)

Download: MOL2 SDF SMILES Flexibase

Physical Representations

Type pH range xlogP Des A‑Pol Apolar desolvation (kcal/mol) Des Pol Polar desolvation (kcal/mol) H Don H-bond donors H Acc H-bond acceptors Chg Net charge tPSA (Ų) MWT Molecular weight (g/mol) RB Rotatable bonds DL
Ref Reference (pH 7) -5.70 -20.94 -308.55 19 15 4 289 488.535 6
Hi High (pH 8-9.5) -5.70 -21.74 -115.97 17 15 2 286 486.519 6
Hi High (pH 8-9.5) -5.70 -21.79 -130.76 17 15 2 286 486.519 6
Mid Mid (pH 6-8) -5.70 -21.34 -233.31 18 15 3 287 487.527 6

Vendor Notes

Note Type Comments Provided By
ALOGPS_SOLUBILITY 9.23e+01 g/l DrugBank-approved
UniProt Database Links AAC31_SALSP; AAC32_SALSP; AAC3_SERMA; AAC6C_SERMA; AAC6_ACIBA; AAC6_ACIG1; AAC6_ACIHA; AAC6_CITKO; AAC6_ENTAE; AAC6_KLEPN; AAC6_MORMO; AAC6_SALEN; AAC6_SALTY; AAC6_SERMA; AAC6_STEMA; AACA_ENTFA; AACA_ENTFC; AACA_STAAM; AACA_STAAU; AACA_STAEQ; AACA_STAHJ ChEBI
Therapy antibacterial SMDC MicroSource
Patent Database Links EP1579873; EP1625855; EP1808081; US2008241102 ChEBI
UniProt Database Links KKA1_ECOLX; KKA1_SALTM; KKA2_KLEPN; KKA3_ENTFL; KKA3_STAAU; KKA4_BACCI; KKA5_STRFR; KKA6_ACIBA; KKA7_CAMJU; KKA8_ECOLX; KKA9_STRRI; KKIH_LACLA; TOBZ_STRSD ChEBI

Activity (Go SEA)

Analogs ( Draw Identity 99% 90% 80% 70% )